{"id":"NCT01098266","sponsor":"AGC Biologics S.p.A.","briefTitle":"NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed","officialTitle":"NGR015: Randomized Double-blind Phase III Study of NGR-hTNF Plus Best Investigator's Choice (BIC) Versus Placebo Plus BIC in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma (MPM)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-04-12","primaryCompletion":"2014-04-29","completion":"2017-12","firstPosted":"2010-04-02","resultsPosted":"2019-09-17","lastUpdate":"2019-09-17"},"enrollment":400,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Malignant Pleural Mesothelioma"],"interventions":[{"type":"DRUG","name":"NGR-hTNF plus Best Investigator's Choice (BIC)","otherNames":["NGR-hTNF+BIC"]},{"type":"DRUG","name":"Placebo plus Best Investigator's Choice (BIC)","otherNames":["Placebo+BIC"]}],"arms":[{"label":"A: NGR-hTNF + BIC","type":"EXPERIMENTAL"},{"label":"B: Placebo+BIC","type":"PLACEBO_COMPARATOR"}],"summary":"The main objective of the trial is to document the efficacy of NGR-hTNF administered at low dose weekly in advanced Malignant Pleural Mesothelioma patients previously treated with a pemetrexed-based chemotherapy regimen.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From date of randomization until the date of first documented progression or date of death from any cause, wichever came first, assesed up to 48 months","effectByArm":[{"arm":"A: NGR-hTNF + BIC","deltaMin":8.5,"sd":null},{"arm":"B: Placebo+BIC","deltaMin":8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.58"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":9},"locations":{"siteCount":49,"countries":["United States","Belgium","Canada","Egypt","France","Ireland","Italy","Netherlands","Poland","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["29753703"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":56,"n":193},"commonTop":["Fatigue","Pain","Chills","Nausea","Dysponoea"]}}